Troxacitabine diphosphate – CAS 182482-79-7

Troxacitabine diphosphate – CAS 182482-79-7 is synthesised by Sigut Labs (Prague, Czech Republic).

Purity (LC-MS)

97%+

Package contents

Troxacitabine diphosphate Et3NH+ salt

This compound is for research use only. We do not sell to patients.

 

Amount
1 mg
€ 5000

Stock

Do you want custom amount?
Custom amount
Amount
1 mg
€ 5000

Stock

Do you want custom amount?
Custom amount

Characterisation

CAS: 182482-79-7
IUPAC name: ((2S,4S)-4-(4-amino-2-oxopyrimidin-1(2H)-yl)-1,3-dioxolan-2-yl)methyl trihydrogen diphosphate
Other names: L-OddCDP  
Molecular weight: 373.15 g/mol
Molecular formula: C8H13N3O10P2
InChI: InChI=1S/C8H13N3O10P2/c9-5-1-2-11(8(12)10-5)6-3-18-7(20-6)4-19-23(16,17)21-22(13,14)15/h1-2,6-7H,3-4H2,(H,16,17)(H2,9,10,12)(H2,13,14,15)/t6-,7-/m0/s1

Description

Troxacitabine diphosphate is the metabolite of a drug called Troxacitabine. Its use is being studied in patients with refractory lymphoproliferative diseases.

Chemicals are distributed worldwide

Buy Troxacitabine diphosphate now, and get your order in 48 hours

  • Shipping through DHL in 48 hours
  • Sensitive compounds are shipped on dry ice
  • All compounds are safely and rigorously packed

Payment

  • Payment terms 30 days net
  • We are sending the invoice the same day as the shipment
  • We are able to modify the invoice for the academic institution, so the order can be paid from grants

References

  • Gourdeau, H., Clarke, M. L., Ouellet, F., Mowles, D., Selner, M., Richard, A., … & Cass, C. E. (2001). Mechanisms of uptake and resistance to troxacitabine, a novel deoxycytidine nucleoside analogue, in human leukemic and solid tumor cell lines. Cancer research61(19), 7217-7224.
  • Sabini, E., Hazra, S., Konrad, M., Burley, S. K., & Lavie, A. (2007). Structural basis for activation of the therapeutic L-nucleoside analogs 3TC and troxacitabine by human deoxycytidine kinase. Nucleic acids research35(1), 186-192.
  • Bouffard, D. Y., Jolivet, J., Leblond, L., Hamelin, B., Ouellet, F., Barbeau, S., … & Gourdeau, H. (2003). Complementary antineoplastic activity of the cytosine nucleoside analogues troxacitabine (Troxatyl) and cytarabine in human leukemia cells. Cancer chemotherapy and pharmacology52, 497-506.
bg molecul blue light

Didn't find the chemical you were looking for?

Contact us
Contact
Kryštof

Get in touch

Krystof Sigut, CEO and Founder

WHY CHOOSE
SigutLabs

Your impossible is our starting line

Located in Prague, Czech Republic, EU
Versatile, seasoned all-PhD team
Global delivery with Silicon Valley clients
Open communication, reliable approach
Verifying quality of all produced substances
95% shipments delivered within 2 days

Partners & distributors

logo partner
logo partner
logo partner
logo partner
logo partner
logo partner
logo partner
logo partner
logo partner
logo partner